Last 12 months
Inside the activity.
21 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 11 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 8 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 21, 2021 Filed Jul 23, 2021 15:31 UTC |
Cornish MeganDirector
|
Grantcommon stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-003696 · form4-07232021_080749.xml · nonDerivative · entry 1 Cornish Megan · CIK 0001832041 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 F1 · shares: Represents 10,000 shares of restricted stock granted to the reporting person pursuant to the Sensus Healthcare, Inc. 2017 Equity Incentive Plan which will vest in four equal annual installments beginning on the first anniversary of the date of grant. Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 15:18 UTC |
Sardano MichaelGENERAL COUNSEL
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-003692 · form4-07232021_080711.xml · nonDerivative · entry 1 Sardano Michael · CIK 0001720602 · GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,454 F1 · shares: Represents 40,000 shares of restricted stock granted to the reporting person pursuant to the Sensus Healthcare, Inc. 2017 Equity Incentive Plan which will vest in four equal annual installments beginning on the first anniversary of the date of grant. Read SEC document |
| July 21, 2021 Filed Mar 8, 2022 13:34 UTC |
Rampolla JavierCHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 2,345 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002727 · form4-03082022_100313.xml · nonDerivative · entry 4 Rampolla Javier · CIK 0001800068 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,791 F1 · balance_after: The amounts shown have been adjusted to correct errors in previous filings. Read SEC document |
| July 21, 2021 Filed Jul 17, 2024 09:15 UTC Amendment |
McCall William HDirector
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-019617 · form4a-07172024_010708.xml · nonDerivative · entry 1 McCall William H · CIK 0001670233 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 F1 · shares: Represents 10,000 shares of restricted stock granted to the reporting person pursuant to the Sensus Healthcare, Inc. 2017 Equity Incentive Plan which will vest in four equal annual installments beginning on the first anniversary of the date of grant. F2 · balance_after: On July 23, 2021, the reporting person filed a Form 4 that inadvertently reported that, following the reported transaction, the reporting person beneficially owned 335,723 shares directly. This Form 4 is being amended to reflect the correct amount of shares beneficially owned, directly and indirectly, by the reporting person following the reported transaction. Read SEC document |
| February 09, 2021 Filed Apr 27, 2021 13:51 UTC |
Rampolla JavierCHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 742 | $3.75 | $2,782.50 |
DisclosureSEC source: 0001415889-21-002118 · form4-04272021_100406.xml · nonDerivative · entry 1 Rampolla Javier · CIK 0001800068 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,636 F1 · shares: Represents shares withheld to pay the reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock. Transaction is being reported late as a result of administrative oversight. Read SEC document |
| February 09, 2021 Filed Apr 27, 2021 17:57 UTC |
Soro NicolasCHIEF OPERATING OFFICER
|
Tax withholdingCommon Stock | 742 | $3.75 | $2,782.50 |
DisclosureSEC source: 0001415889-21-002122 · form4-04272021_100439.xml · nonDerivative · entry 1 Soro Nicolas · CIK 0001800450 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,788 F1 · shares: Represents shares withheld to pay the reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock. Transaction is being reported late as a result of administrative oversight. Read SEC document |
| June 30, 2020 Filed Apr 27, 2021 15:13 UTC |
McCall William HDirector
|
PurchaseCommon Stock | 3,900 | $2.99 | $11,661.00 |
DisclosureSEC source: 0001415889-21-002128 · form5-04272021_120441.xml · nonDerivative · entry 12 McCall William H · CIK 0001670233 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Investors Capital Alliance, LLC Disclosed balance after: 325,723 F1 · shares: Transaction is being reported late as a result of administrative oversight. F2 · ownership.nature: Represents shares of Common Stock of Sensus Healthcare, Inc. held by Investors Capital Alliance, LLC, for which the reporting person serves as managing partner and over which the reporting person has voting and dispositive power. Read SEC document |
| June 29, 2020 Filed Apr 27, 2021 15:13 UTC |
McCall William HDirector
|
PurchaseCommon Stock | 2,000 | $2.97 | $5,940.00 |
DisclosureSEC source: 0001415889-21-002128 · form5-04272021_120441.xml · nonDerivative · entry 11 McCall William H · CIK 0001670233 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Investors Capital Alliance, LLC Disclosed balance after: 321,823 F1 · shares: Transaction is being reported late as a result of administrative oversight. F2 · ownership.nature: Represents shares of Common Stock of Sensus Healthcare, Inc. held by Investors Capital Alliance, LLC, for which the reporting person serves as managing partner and over which the reporting person has voting and dispositive power. Read SEC document |
| June 26, 2020 Filed Apr 27, 2021 15:13 UTC |
McCall William HDirector
|
PurchaseCommon Stock | 10,000 | $2.94 | $29,400.00 |
DisclosureSEC source: 0001415889-21-002128 · form5-04272021_120441.xml · nonDerivative · entry 10 McCall William H · CIK 0001670233 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Investors Capital Alliance, LLC Disclosed balance after: 319,823 F1 · shares: Transaction is being reported late as a result of administrative oversight. F2 · ownership.nature: Represents shares of Common Stock of Sensus Healthcare, Inc. held by Investors Capital Alliance, LLC, for which the reporting person serves as managing partner and over which the reporting person has voting and dispositive power. Read SEC document |
| June 25, 2020 Filed Apr 27, 2021 15:13 UTC |
McCall William HDirector
|
PurchaseCommon Stock | 10,000 | $3.03 | $30,300.00 |
DisclosureSEC source: 0001415889-21-002128 · form5-04272021_120441.xml · nonDerivative · entry 9 McCall William H · CIK 0001670233 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Investors Capital Alliance, LLC Disclosed balance after: 309,823 F1 · shares: Transaction is being reported late as a result of administrative oversight. F2 · ownership.nature: Represents shares of Common Stock of Sensus Healthcare, Inc. held by Investors Capital Alliance, LLC, for which the reporting person serves as managing partner and over which the reporting person has voting and dispositive power. Read SEC document |
| June 24, 2020 Filed Apr 27, 2021 15:13 UTC |
McCall William HDirector
|
PurchaseCommon Stock | 10,000 | $3.04 | $30,400.00 |
DisclosureSEC source: 0001415889-21-002128 · form5-04272021_120441.xml · nonDerivative · entry 8 McCall William H · CIK 0001670233 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Investors Capital Alliance, LLC Disclosed balance after: 299,823 F1 · shares: Transaction is being reported late as a result of administrative oversight. F2 · ownership.nature: Represents shares of Common Stock of Sensus Healthcare, Inc. held by Investors Capital Alliance, LLC, for which the reporting person serves as managing partner and over which the reporting person has voting and dispositive power. Read SEC document |
| June 23, 2020 Filed Apr 27, 2021 15:13 UTC |
McCall William HDirector
|
PurchaseCommon Stock | 10,000 | $3.05 | $30,500.00 |
DisclosureSEC source: 0001415889-21-002128 · form5-04272021_120441.xml · nonDerivative · entry 7 McCall William H · CIK 0001670233 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Investors Capital Alliance, LLC Disclosed balance after: 289,823 F1 · shares: Transaction is being reported late as a result of administrative oversight. F2 · ownership.nature: Represents shares of Common Stock of Sensus Healthcare, Inc. held by Investors Capital Alliance, LLC, for which the reporting person serves as managing partner and over which the reporting person has voting and dispositive power. Read SEC document |
| June 23, 2020 Filed Apr 27, 2021 15:13 UTC |
McCall William HDirector
|
PurchaseCommon Stock | 10,000 | $3.05 | $30,500.00 |
DisclosureSEC source: 0001415889-21-002128 · form5-04272021_120441.xml · nonDerivative · entry 6 McCall William H · CIK 0001670233 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Investors Capital Alliance, LLC Disclosed balance after: 279,823 F1 · shares: Transaction is being reported late as a result of administrative oversight. F2 · ownership.nature: Represents shares of Common Stock of Sensus Healthcare, Inc. held by Investors Capital Alliance, LLC, for which the reporting person serves as managing partner and over which the reporting person has voting and dispositive power. Read SEC document |
| June 19, 2020 Filed Apr 27, 2021 15:13 UTC |
McCall William HDirector
|
PurchaseCommon Stock | 1,203 | $3.10 | $3,729.30 |
DisclosureSEC source: 0001415889-21-002128 · form5-04272021_120441.xml · nonDerivative · entry 5 McCall William H · CIK 0001670233 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Investors Capital Alliance, LLC Disclosed balance after: 269,823 F1 · shares: Transaction is being reported late as a result of administrative oversight. F2 · ownership.nature: Represents shares of Common Stock of Sensus Healthcare, Inc. held by Investors Capital Alliance, LLC, for which the reporting person serves as managing partner and over which the reporting person has voting and dispositive power. Read SEC document |
| June 18, 2020 Filed Apr 27, 2021 15:13 UTC |
McCall William HDirector
|
PurchaseCommon Stock | 10,000 | $3.04 | $30,400.00 |
DisclosureSEC source: 0001415889-21-002128 · form5-04272021_120441.xml · nonDerivative · entry 4 McCall William H · CIK 0001670233 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Investors Capital Alliance, LLC Disclosed balance after: 268,620 F1 · shares: Transaction is being reported late as a result of administrative oversight. F2 · ownership.nature: Represents shares of Common Stock of Sensus Healthcare, Inc. held by Investors Capital Alliance, LLC, for which the reporting person serves as managing partner and over which the reporting person has voting and dispositive power. Read SEC document |
| June 17, 2020 Filed Apr 27, 2021 15:13 UTC |
McCall William HDirector
|
PurchaseCommon Stock | 10,000 | $2.99 | $29,900.00 |
DisclosureSEC source: 0001415889-21-002128 · form5-04272021_120441.xml · nonDerivative · entry 3 McCall William H · CIK 0001670233 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Investors Capital Allilance, LLC Disclosed balance after: 258,620 F1 · shares: Transaction is being reported late as a result of administrative oversight. F2 · ownership.nature: Represents shares of Common Stock of Sensus Healthcare, Inc. held by Investors Capital Alliance, LLC, for which the reporting person serves as managing partner and over which the reporting person has voting and dispositive power. Read SEC document |
| June 16, 2020 Filed Apr 27, 2021 15:13 UTC |
McCall William HDirector
|
PurchaseCommon Stock | 10,000 | $3.07 | $30,700.00 |
DisclosureSEC source: 0001415889-21-002128 · form5-04272021_120441.xml · nonDerivative · entry 2 McCall William H · CIK 0001670233 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Investors Capital Alliance, LLC Disclosed balance after: 248,620 F1 · shares: Transaction is being reported late as a result of administrative oversight. F2 · ownership.nature: Represents shares of Common Stock of Sensus Healthcare, Inc. held by Investors Capital Alliance, LLC, for which the reporting person serves as managing partner and over which the reporting person has voting and dispositive power. Read SEC document |
| June 15, 2020 Filed Apr 27, 2021 15:13 UTC |
McCall William HDirector
|
PurchaseCommon Stock | 10,000 | $3.01 | $30,100.00 |
DisclosureSEC source: 0001415889-21-002128 · form5-04272021_120441.xml · nonDerivative · entry 1 McCall William H · CIK 0001670233 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Investors Capital Alliance, LLC Disclosed balance after: 238,620 F1 · shares: Transaction is being reported late as a result of administrative oversight. F2 · ownership.nature: Represents shares of Common Stock of Sensus Healthcare, Inc. held by Investors Capital Alliance, LLC, for which the reporting person serves as managing partner and over which the reporting person has voting and dispositive power. Read SEC document |
| June 02, 2020 Filed Jun 10, 2020 15:49 UTC |
Rampolla JavierCHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 1,186 | $3.05 | $3,617.30 |
DisclosureSEC source: 0001415889-20-001540 · form4-06102020_120600.xml · nonDerivative · entry 1 Rampolla Javier · CIK 0001800068 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,628 F1 · shares: Represents shares withheld to pay the reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock. Read SEC document |
| June 02, 2020 Filed Jun 10, 2020 19:52 UTC |
Sardano MichaelGENERAL COUNSEL
|
Tax withholdingCommon Stock | 1,483 | $3.05 | $4,523.15 |
DisclosureSEC source: 0001415889-20-001541 · form4-06102020_120611.xml · nonDerivative · entry 1 Sardano Michael · CIK 0001720602 · GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,454 F1 · shares: Represents shares withheld to pay the reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock. Read SEC document |
| June 02, 2020 Filed Apr 27, 2021 13:48 UTC Amendment |
Rampolla JavierCHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 1,186 | $3.05 | $3,617.30 |
DisclosureSEC source: 0001415889-21-002116 · form4a-04272021_100427.xml · nonDerivative · entry 1 Rampolla Javier · CIK 0001800068 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,878 F1 · shares: Represents shares withheld to pay the reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock. F2 · balance_after: Amendment of Common Stock beneficially owned is being updated to correct an administrative oversight. Read SEC document |
| February 01, 2020 Filed Apr 27, 2021 13:54 UTC |
Rampolla JavierCHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-002120 · form5-04272021_100452.xml · nonDerivative · entry 1 Rampolla Javier · CIK 0001800068 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,064 F1 · shares: Represents 10,000 shares of restricted stock granted to the reporting person pursuant to the Sensus Healthcare, Inc. 2017 Equity Incentive Plan which will vest in four equal annual installments beginning on the first anniversary of the date of grant. Transaction is being reported late as a result of administrative oversight. Read SEC document |
| February 01, 2020 Filed Apr 27, 2021 18:00 UTC |
Soro NicolasCHIEF OPERATING OFFICER
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-002124 · form5-04272021_110422.xml · nonDerivative · entry 1 Soro Nicolas · CIK 0001800450 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,030 F1 · shares: Represents 10,000 shares of restricted stock granted to the reporting person pursuant to the Sensus Healthcare, Inc. 2017 Equity Incentive Plan which will vest in four equal annual installments beginning on the first anniversary of the date of grant. Transaction is being reported late as a result of administrative oversight. Read SEC document |
| June 02, 2019 Filed Jun 4, 2019 19:39 UTC |
Sardano MichaelGENERAL COUNSEL
|
Tax withholdingCommon Stock | 1,948 | $5.59 | $10,889.32 |
DisclosureSEC source: 0001415889-19-000646 · form4-06042019_120604.xml · nonDerivative · entry 1 Sardano Michael · CIK 0001720602 · GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,937 F1 · shares: Represents shares withheld to pay the reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock. Read SEC document |
| June 02, 2019 Filed Jun 4, 2019 19:32 UTC |
Levine ArthurCHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 14,628 | $5.59 | $81,770.52 |
DisclosureSEC source: 0001415889-19-000645 · form4-06042019_120623.xml · nonDerivative · entry 1 Levine Arthur · CIK 0001351380 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,709 F1 · shares: Represents shares withheld to pay the reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock. Read SEC document |
| March 22, 2019 Filed Mar 22, 2019 17:14 UTC |
Golin RichardEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 492 | $7.50 | $3,690.00 |
DisclosureSEC source: 0001415889-19-000377 · form4-03222019_020309.xml · nonDerivative · entry 3 Golin Richard · CIK 0001670070 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 924,236 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in February 2019. Read SEC document |
| March 22, 2019 Filed Mar 26, 2019 17:35 UTC |
Fishman KalmanCHIEF TECHNOLOGY OFFICER
|
SaleCommon Stock | 173 | $7.50 | $1,297.50 |
DisclosureSEC source: 0001415889-19-000390 · form4-03262019_020318.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 931,007 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in February 2019. Read SEC document |
| March 22, 2019 Filed Mar 26, 2019 17:33 UTC |
Cohen Stephen BradEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 595 | $7.50 | $4,462.50 |
DisclosureSEC source: 0001415889-19-000388 · form4-03262019_020356.xml · nonDerivative · entry 1 Cohen Stephen Brad · CIK 0001670284 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 930,585 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in February 2019. Read SEC document |
| March 21, 2019 Filed Mar 22, 2019 17:14 UTC |
Golin RichardEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 509 | $7.50 | $3,817.50 |
DisclosureSEC source: 0001415889-19-000377 · form4-03222019_020309.xml · nonDerivative · entry 2 Golin Richard · CIK 0001670070 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 924,728 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in February 2019. F3 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.52. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 17:14 UTC |
Golin RichardEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 5,943 | $7.56 | $44,929.08 |
DisclosureSEC source: 0001415889-19-000377 · form4-03222019_020309.xml · nonDerivative · entry 1 Golin Richard · CIK 0001670070 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 925,237 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in February 2019. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.80. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| September 11, 2018 Filed Sep 12, 2018 21:27 UTC |
Fishman KalmanCHIEF TECHNOLOGY OFFICER
|
SaleCommon Stock | 631 | $7.51 | $4,738.81 |
DisclosureSEC source: 0001415889-18-001374 · form4-09122018_060911.xml · nonDerivative · entry 2 Fishman Kalman · CIK 0001670242 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 931,180 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F3 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.53. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| September 11, 2018 Filed Sep 12, 2018 21:25 UTC |
Cohen Stephen BradEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 631 | $7.51 | $4,738.81 |
DisclosureSEC source: 0001415889-18-001373 · form4-09122018_060942.xml · nonDerivative · entry 2 Cohen Stephen Brad · CIK 0001670284 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 931,180 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F3 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.53. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| September 11, 2018 Filed Sep 12, 2018 21:28 UTC |
Golin RichardEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 631 | $7.51 | $4,738.81 |
DisclosureSEC source: 0001415889-18-001375 · form4-09122018_060922.xml · nonDerivative · entry 2 Golin Richard · CIK 0001670070 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 931,180 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F3 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.53. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| September 11, 2018 Filed Sep 13, 2018 01:29 UTC |
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 1,052 | $7.51 | $7,900.52 |
DisclosureSEC source: 0001415889-18-001376 · form4-09122018_060934.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,538,649 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F3 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.53. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| September 11, 2018 Filed Sep 13, 2018 01:24 UTC |
Levine ArthurCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 60 | $7.51 | $450.60 |
DisclosureSEC source: 0001415889-18-001372 · form4-09122018_060910.xml · nonDerivative · entry 2 Levine Arthur · CIK 0001351380 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,337 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F3 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.53. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| September 10, 2018 Filed Sep 12, 2018 21:27 UTC |
Fishman KalmanCHIEF TECHNOLOGY OFFICER
|
SaleCommon Stock | 1,114 | $7.55 | $8,410.70 |
DisclosureSEC source: 0001415889-18-001374 · form4-09122018_060911.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 931,811 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.56. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| September 10, 2018 Filed Sep 12, 2018 21:25 UTC |
Cohen Stephen BradEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 1,114 | $7.55 | $8,410.70 |
DisclosureSEC source: 0001415889-18-001373 · form4-09122018_060942.xml · nonDerivative · entry 1 Cohen Stephen Brad · CIK 0001670284 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 931,811 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.56. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| September 10, 2018 Filed Sep 12, 2018 21:28 UTC |
Golin RichardEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 1,114 | $7.55 | $8,410.70 |
DisclosureSEC source: 0001415889-18-001375 · form4-09122018_060922.xml · nonDerivative · entry 1 Golin Richard · CIK 0001670070 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 931,811 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.56. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:29 UTC |
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 1,857 | $7.55 | $14,020.35 |
DisclosureSEC source: 0001415889-18-001376 · form4-09122018_060934.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,539,701 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.56. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:24 UTC |
Levine ArthurCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 106 | $7.55 | $800.30 |
DisclosureSEC source: 0001415889-18-001372 · form4-09122018_060910.xml · nonDerivative · entry 1 Levine Arthur · CIK 0001351380 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,397 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.56. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| August 29, 2018 Filed Aug 30, 2018 16:19 UTC |
Fishman KalmanCHIEF TECHNOLOGY OFFICER
|
SaleCommon Stock | 193 | $7.50 | $1,447.50 |
DisclosureSEC source: 0001415889-18-001306 · form4-08302018_010803.xml · nonDerivative · entry 2 Fishman Kalman · CIK 0001670242 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 932,925 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 29, 2018 Filed Aug 30, 2018 16:17 UTC |
Cohen Stephen BradEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 193 | $7.50 | $1,447.50 |
DisclosureSEC source: 0001415889-18-001305 · form4-08302018_010854.xml · nonDerivative · entry 2 Cohen Stephen Brad · CIK 0001670284 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 932,925 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 29, 2018 Filed Aug 30, 2018 16:20 UTC |
Golin RichardEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 193 | $7.50 | $1,447.50 |
DisclosureSEC source: 0001415889-18-001307 · form4-08302018_010808.xml · nonDerivative · entry 2 Golin Richard · CIK 0001670070 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 932,925 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 29, 2018 Filed Aug 30, 2018 20:22 UTC |
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 322 | $7.50 | $2,415.00 |
DisclosureSEC source: 0001415889-18-001308 · form4-08302018_010849.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,541,558 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 29, 2018 Filed Aug 30, 2018 20:15 UTC |
Levine ArthurCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 19 | $7.50 | $142.50 |
DisclosureSEC source: 0001415889-18-001304 · form4-08302018_010825.xml · nonDerivative · entry 2 Levine Arthur · CIK 0001351380 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,503 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 28, 2018 Filed Aug 30, 2018 16:19 UTC |
Fishman KalmanCHIEF TECHNOLOGY OFFICER
|
SaleCommon Stock | 699 | $7.50 | $5,242.50 |
DisclosureSEC source: 0001415889-18-001306 · form4-08302018_010803.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 933,118 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 28, 2018 Filed Aug 30, 2018 16:17 UTC |
Cohen Stephen BradEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 699 | $7.50 | $5,242.50 |
DisclosureSEC source: 0001415889-18-001305 · form4-08302018_010854.xml · nonDerivative · entry 1 Cohen Stephen Brad · CIK 0001670284 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 933,118 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 28, 2018 Filed Aug 30, 2018 16:20 UTC |
Golin RichardEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 699 | $7.50 | $5,242.50 |
DisclosureSEC source: 0001415889-18-001307 · form4-08302018_010808.xml · nonDerivative · entry 1 Golin Richard · CIK 0001670070 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 933,118 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 28, 2018 Filed Aug 30, 2018 20:22 UTC |
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 1,166 | $7.50 | $8,745.00 |
DisclosureSEC source: 0001415889-18-001308 · form4-08302018_010849.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,541,880 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 28, 2018 Filed Aug 30, 2018 20:15 UTC |
Levine ArthurCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 67 | $7.50 | $502.50 |
DisclosureSEC source: 0001415889-18-001304 · form4-08302018_010825.xml · nonDerivative · entry 1 Levine Arthur · CIK 0001351380 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,522 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.